首页> 美国卫生研究院文献>other >Nanoparticle Drug Loading as a Design Parameter to Improve Docetaxel Pharmacokinetics and Efficacy
【2h】

Nanoparticle Drug Loading as a Design Parameter to Improve Docetaxel Pharmacokinetics and Efficacy

机译:纳米颗粒药物负载作为提高多西他赛药代动力学和功效的设计参数

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nanoparticle (NP) drug loading is one of the key defining characteristics of a NP formulation. However, the effect of NP drug loading on therapeutic efficacy and pharmacokinetics has not been thoroughly evaluated. Herein, we characterized the efficacy, toxicity and pharmacokinetic properties of NP docetaxel formulations that have differential drug loading but are otherwise identical. Particle Replication in Non-wetting Templates (PRINT®), a soft-lithography fabrication technique, was used to formulate NPs with identical size, shape and surface chemistry, but with variable docetaxel loading. The lower weight loading (9%-NP) of docetaxel was found to have a superior pharmacokinetic profile and enhanced efficacy in a murine cancer model when compared to that of a higher docetaxel loading (20%-NP). The 9%-NP docetaxel increased plasma and tumor docetaxel exposure and reduced liver, spleen and lung exposure when compared to that of 20%-NP docetaxel.
机译:纳米颗粒(NP)的载药量是NP制剂的关键定义特征之一。但是,尚未完全评估NP药物负荷对治疗功效和药代动力学的影响。本文中,我们表征了NP多西他赛制剂的功效,毒性和药代动力学特性,这些制剂具有不同的药物载量,但在其他方面相同。非润湿模板中的粒子复制(PRINT ®)是一种软光刻制造技术,用于配制尺寸,形状和表面化学性质相同但多西紫杉醇载量可变的NP。与高紫杉醇载量(20%-NP)相比,紫杉醇的较低重量载量(9%-NP)在鼠癌模型中具有优异的药代动力学特征和增强的功效。与20%-NP多西紫杉醇相比,9%-NP多西紫杉醇可增加血浆和肿瘤多西紫杉醇的暴露,并减少肝,脾和肺的暴露。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号